author-photo

Burcu Aslan

University of Texas MD Anderson Cancer Center

26

Papers

608

Citations

Citation Trend

Filter By

Papers (22) Sort By

Journal Conference Others

Development and characterization of prototypes for in vitro and in vivo mouse models of ibrutinib-resistant CLL.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
ncRNA Therapy with miRNA-22-3p- Suppresses the Growth of Triple-Negative Breast Cancer

2021 Molecular therapy. Nucleic acids
Show All
- Source
- Cite
- Save
Citations (6)
Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112]

2020 EBioMedicine
Show All
- Source
- Cite
- Save
Citations (0)
AMG-176, an Mcl-1 antagonist, shows preclinical efficacy in chronic lymphocytic leukemia

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (22)
Ex Vivo Pharmacological Profiling in Chronic Lymphocytic Leukemia Cells

2019 Methods of Molecular Biology
Show All
- Source
- Cite
- Save
Citations (0)
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis

2019 EBioMedicine
Show All
- Source
- Cite
- Save
Citations (13)
Abstract 317: Vecabrutinib inhibits C481 mutated Bruton's tyrosine kinase and its downstream signaling in vitro

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer

2018 EBioMedicine
Show All
- Source
- Cite
- Save
Citations (82)
OKUL ÖNCESİ DÖNEMDE BESİNLER KONUSUNUN YARATICI DRAMA UYGULAMALARIYLA ÖĞRETİLMESİNİN ÖĞRENME DÜZEYİNE ETKİSİ

2018
- Yilmaz Kara
- Burcu Aslan
Show All
- Source
- Cite
- Save
Citations (0)
MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase

2017 Oncotarget
Show All
- Source
- Cite
- Save
Citations (49)